Product Description
CK2 inhibitor selectively inhibits casein kinase 2 (CK2) with an IC₅₀ of 0.125 μM. CK2 is a potential protein kinase target for the development of antitumor, antiviral and anti-inflammatory drugs.
CK2 inhibitor selectively inhibits casein kinase 2 (CK2) with an IC₅₀ of 0.125 μM. CK2 is a potential protein kinase target for the development of antitumor, antiviral and anti-inflammatory drugs.
Biovision | B2935 | CK2 inhibitor DataSheet
Alternate Name/Synonyms: 3-{[5-(4-ethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]thio}propanoic acid
Appearance: Solid
Formulation:
CAS Number: 1181227-92-8
Structure Available?: True
Peptide sequence:
Salt Form: false
Molecular Formula: C₁₇H₁₆N₂O₃S₂
Molecular Weight: 360.45
Cell-Permeable?: True
Purity: 95%
Solubilities: Soluble in in DMSO
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An inhibitor of CK2
MDL Number:
PubChem CID:
SMILES: O=C(O)CCSC1=C(C(C2=CC=C(OCC)C=C2)=CS3)C3=NC=N1
InChi: InChI=1S/C17H16N2O3S2/c1-2-22-12-5-3-11(4-6-12)13-9-24-17-15(13)16(18-10-19-17)23-8-7-14(20)21/h3-6,9-10H,2,7-8H2,1H3,(H,20,21)
InChi Key: BRXZQBGAUIEEBL-UHFFFAOYSA-N